Found: 19
Select item for more details and to access through your institution.
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-02923-9
- By:
- Publication type:
- Article
CAR-T cell combination therapy: the next revolution in cancer treatment.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02778-6
- By:
- Publication type:
- Article
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID‐19 patients.
- Published in:
- Journal of Cellular Physiology, 2021, v. 236, n. 7, p. 5325, doi. 10.1002/jcp.30233
- By:
- Publication type:
- Article
Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls.
- Published in:
- Journal of Cellular Physiology, 2021, v. 236, n. 4, p. 2829, doi. 10.1002/jcp.30047
- By:
- Publication type:
- Article
The outlook for diagnostic purposes of the 2019‐novel coronavirus disease.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 12, p. 9211, doi. 10.1002/jcp.29804
- By:
- Publication type:
- Article
Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01717
- By:
- Publication type:
- Article
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02420-8
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
CAR T cells in solid tumors: challenges and opportunities.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-020-02128-1
- By:
- Publication type:
- Article
Immunogenicity of COVID‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta‐analysis.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 7, p. 1227, doi. 10.1111/1756-185X.14713
- By:
- Publication type:
- Article
Longevity and anti-aging effects of curcumin supplementation.
- Published in:
- GeroScience, 2024, v. 46, n. 3, p. 2933, doi. 10.1007/s11357-024-01092-5
- By:
- Publication type:
- Article
Recent advances in antibody‐based immunotherapy strategies for COVID‐19.
- Published in:
- Journal of Cellular Biochemistry, 2021, v. 122, n. 10, p. 1389, doi. 10.1002/jcb.30017
- By:
- Publication type:
- Article
The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients.
- Published in:
- Cell Biology International, 2021, v. 45, n. 7, p. 1498, doi. 10.1002/cbin.11589
- By:
- Publication type:
- Article
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03525-9
- By:
- Publication type:
- Article
Recent advances in non-small cell lung cancer targeted therapy; an update review.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-02990-y
- By:
- Publication type:
- Article
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies.
- Published in:
- Medical Oncology, 2023, v. 40, n. 5, p. 1, doi. 10.1007/s12032-023-02019-4
- By:
- Publication type:
- Article